New discovery: Vaccinated F0 can avoid Covid-19 for a long time

The researchers followed 6,729 volunteers ages 18 to 69. Those who received two doses of the AstraZeneca vaccine or an mRNA vaccine such as Pfizer, Moderna after contracting Covid-19. And those who got it Covid-19 severely persisted at least once between February and September 2021.

A new study shows that vaccinated F0 can help reduce the burden of lingering Covid-19 symptoms Shutterstock

The results were reported on May 18 in the medical journal BMJ, shows the incidence Covid-19 lasts There was an average reduction of 13% after the first dose of vaccine, a further 9% reduction after the second dose of vaccine.

Specifically, the incidence of Covid-19 lasting 12 weeks or more was reduced by an average of 13% after the dose Vaccine firstly.

For the second dose, the rate fell by an average of 9% more – lasting for at least nine weeks, the researchers said, according to Reuters.

Persistent Covid-19 incidence decreased by an average of 13% after the first dose of vaccine, a further 9% reduction after the second dose of vaccine. Shutterstock

The results also show that the incidence of severe prolonged Covid-19 leading to functional impairment is similarly reduced.

However, the study did not compare the long-term effectiveness of each vaccine against Covid-19, or between severe or mild initial Covid-19 infection.

Further studies are needed to assess the effectiveness of vaccinations against Covid-19 in the long run, the researchers say. Especially for Omicron variant – appeared only later, according to Reuters.